AGE Stock Summary and Trading Ideas (Agex Therapeutics | AMEX:AGE)

AgeX Therapeutics Inc is a biotechnology company engaged in the development and commercialization of novel therapeutics targeting human aging. The firm through its PureStem and induced Tissue Regeneration (iTR) technologies develops medicines designed to address some of the unsolved problems in aging. Its PureStem-derived cell-based therapeutic candidates in development are AGEX-VASC1, AGEX-BAT1 and AGEX-iTR1547.

Agex Therapeutics trades on the AMEX stock market under the symbol AGE.

As of September 29, 2023, AGE stock price was flat at $0.68 with 6,443 million shares trading.

AGE has a beta of 0.63, meaning it tends to be less sensitive to market movements. AGE has a correlation of 0.02 to the broad based SPY ETF.

AGE has a market cap of $25.80 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, AGE stock traded as high as $3.93 and as low as $.37.

The top ETF exchange traded funds that AGE belongs to (by Net Assets): VTI, VXF, ITOT.

AGE has outperformed the market in the last year with a return of +17.2%, while the SPY ETF gained +17.1%. However, in the most recent history, AGE shares have underperformed the stock market with its stock returning -22.1% in the last 3 month period and -13.8% for the last 2 week period, while SPY has returned -1.7% and -4.4%, respectively.

AGE support price is $.63 and resistance is $.73 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AGE stock will trade within this expected range on the day.